A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

Gouty Arthritis Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial, Efficacy and Safety Study of Qingzhu Granules in the Treatment of Acute Gouty Arthritis ( Damp Heat Pattern)

Status Not yet recruiting

Clinical Trial Summary

This study will evaluate the efficacy and safety of Qingzhu Granules in the treatment of Acute Gouty Arthritis ( Damp heat pattern)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06068478
Study type	Interventional
Source	Tasly Pharmaceutical Group Co., Ltd
Contact	Rui Liu
Phone	022-86343626
Email	liurui2@tasly.com
Status	Not yet recruiting
Phase	Phase 3
Start date	October 2023
Completion date	October 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01867840` - Role of ASICs in Human Inflammatory Pain	N/A
Completed	`NCT00927810` - Long Term Study of Canakinumab (ACZ885) in Patients With Gout	Phase 2
Completed	`NCT05332795` - The Impact of Metformin on the Outcome of Gouty Arthritis in a Cohort of Egyptian Gouty Patients.	N/A
Completed	`NCT05964946` - Real-life Study of the Characteristics of Patients Treated With Ilaris® (Canakinumab) for Gouty Arthritis in France
Terminated	`NCT01362608` - Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective	Phase 3
Completed	`NCT01626235` - AMPED Outcomes Registry of Post-ED Pain Management	N/A
Not yet recruiting	`NCT04462666` - Oral Huzhang Granules for Acute Gouty Arthritis	Phase 2
Recruiting	`NCT05658575` - Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/Phase 3